To explore the role of LAPTM5 in ccRCC, the LAPTM5 expression levels were determined in tumor and adjacent healthy tissues of patients with ccRCC obtained from TCGA database and GEO database (GSE 6344 and GSE 781). This evidence concerns the gene LAPTM5 and nonpapillary renal cell carcinoma.